跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 50 条关于
“TRIM3”
全部
50
临床试验
24
药物
9
机构
0
资讯
17
9天前
Redasemtide Clears Ulcer Endpoint in Dystrophic EB but Misses Primary Endpoint in Global Phase 2 Acute Ischemic Stroke Trial
11个月前
Repare Therapeutics to Present First Clinical Data for Novel PLK4 Inhibitor RP-1664 at AACR Conference
2年前
ORIC Pharmaceuticals Presents Promising Data on Cancer Drug Candidates at AACR Meeting
2年前
Repare Therapeutics Prioritizes Clinical Oncology Pipeline, Streamlining Operations
3个月前
Advances in Triple-Negative Breast Cancer: From Preventive Vaccines to ADC Approvals Reshape the Treatment Landscape
2年前
Repare Therapeutics Advances Oncology Pipeline with Multiple Clinical Trials
去年
Repare Therapeutics Reports 52% Reduction in Q2 Loss Amid Strategic Pivot to Licensing Model
去年
Repare Therapeutics Advances Oncology Pipeline with Promising Clinical Data
去年
Repare Therapeutics Licenses PKMYT1 Inhibitor Lunresertib to Debiopharm in $267M Deal
10个月前
Repare Therapeutics Agrees to $1.82 Per Share Acquisition by XenoTherapeutics
第 1 页,共 2 页
上一页
下一页